BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26724283)

  • 1. Medical Therapy Leads to Favorable Remodeling in Left Ventricular Non-compaction Cardiomyopathy: Dilated Phenotype.
    Parent JJ; Towbin JA; Jefferies JL
    Pediatr Cardiol; 2016 Apr; 37(4):674-7. PubMed ID: 26724283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
    Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral endothelial function may predict the effectiveness of beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Xie X; Wu B; Chen Y; Li W; Hu X; Chen J
    Int J Cardiol; 2016 Oct; 221():128-33. PubMed ID: 27400309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac phenotype in propionic acidemia - Results of an observational monocentric study.
    Kovacevic A; Garbade SF; Hoffmann GF; Gorenflo M; Kölker S; Staufner C
    Mol Genet Metab; 2020 May; 130(1):41-48. PubMed ID: 32067920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of left ventricular hypertrabeculation is associated with improvement in systolic function and favorable prognosis in adult patients with non-ischemic cardiomyopathy.
    Minamisawa M; Koyama J; Kozuka A; Miura T; Ebisawa S; Motoki H; Okada A; Izawa A; Ikeda U
    J Cardiol; 2016 Nov; 68(5):431-438. PubMed ID: 26740463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
    Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
    Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy.
    Kawai K; Takaoka H; Hata K; Yokota Y; Yokoyama M
    Am J Cardiol; 1999 Sep; 84(6):671-6. PubMed ID: 10498137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
    Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
    Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial systolic improvement and reverse cardiac remodeling in elderly-onset idiopathic dilated cardiomyopathy > or = 65 years of age.
    Nishida K; Ito H; Fukuyama O
    Hawaii Med J; 2008 Jun; 67(6):156-9. PubMed ID: 18678207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.
    Badenhorst D; Norton GR; Sliwa K; Brooksbank R; Essop R; Sareli P; Woodiwiss AJ
    Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hazards of ventricular pre-excitation to left ventricular systolic function and ventricular wall motion in children: analysis of 25 cases.
    Guo B; Dai C; Li Q; Li W; Han L
    Cardiol Young; 2019 Mar; 29(3):380-388. PubMed ID: 30767835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS
    Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.